Verix to Acquire AI Specialist Team start-up.ai
Group to be fully integrated into Verix lab.
Verix, an artificial intelligence (AI) provider for the pharmaceutical industry, is acquiring start-up.ai, an organization of specialists that helps businesses improve their processes using AI and machine learning. With the team being fully integrated into Verix, startup.ai CEO Shahar Cohen will transition to Verix CTO.
"In our time working with start-up.ai, we were consistently impressed with their AI capabilities and innovative approach to solving customer challenges," said Doron Aspitz, CEO, Verix. "As we continue to grow, serving more and more customers, we understand the strategic value of continuing to build out category-leading AI capabilities, which are embedded in our opportunity engine platform "Tovana". Adding the start-up.ai team to Verix was a natural decision for us and we are excited for what our new capabilities will enable us to deliver to our customers and partners around the world."
Reference: Verix Acquires start-up.ai, Further Enhancing its Capabilities to Leverage the Power of AI to accelerate brand growth for life Science Companies. PR Newswire. June 15, 2023. Accessed June 22, 2023. https://www.prnewswire.com/news-releases/verix-acquires-start-upai-further-enhancing-its-capabilities-to-leverage-the-power-of-ai-to-accelerate-brand-growth-for-life-science-companies-301851916.html
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
